Ritonavir-Mediated Induction of Apoptosis in Pancreatic Cancer Occurs via the RB/E2F-1 and AKT Pathways
Recent observations suggest a lower incidence of malignancies in patients infected with HIV during treatment with Highly Active Anti-Retroviral Therapy (HAART) utilizing protease inhibitors. We investigated the effects of ritonavir, a FDA approved HIV protease inhibitor, on proliferation of pancreat...
Main Authors: | Batchu, Ramesh B., Gruzdyn, Oksana V., Bryant, Christopher S., Qazi, Aamer M., Kumar, Sanjeev, Chamala, Sreedhar, Kung, Shu T., Sanka, Ramana S., Puttagunta, Udaya S., Weaver, Donald W., Gruber, Scott A. |
---|---|
Format: | Online |
Language: | English |
Published: |
MDPI
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915194/ |
Similar Items
-
Ritonavir inhibits NF-AT activation through modulation of the PI-3 kinase/Akt Ppathway
by: Pati, Shibani, et al.
Published: (2006) -
Lopinavir/ritonavir monotherapy in clinical practice
by: Caso, A, et al.
Published: (2010) -
Metabolic: week 48 comparison of metabolic parameters and biomarkers in subjects receiving darunavir/ritonavir or atazanavir/ritonavir
by: Overton, T, et al.
Published: (2010) -
Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
by: Broder, MS, et al.
Published: (2010) -
Ritonavir-Boosted Darunavir Is Rarely Associated with Nephrolithiasis Compared with Ritonavir-Boosted Atazanavir in HIV-Infected Patients
by: Nishijima, Takeshi, et al.
Published: (2013)